June; Carl

Patent Applications and Registrations

Patent applications and USPTO patent grants for June; Carl.The latest application filed is for "methods and compositions comprising a viral vector for expression of a transgene and an effector".

Company Profile

1.14.16

June; Carl - Merion Station PA
June; Carl - Nerion Station PA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Methods And Compositions Comprising A Viral Vector For Expression Of A Transgene And An Effector App 20210032661 - Powell; Daniel J. ; et al.	2021-02-04
Methods for the isolation and expansion of cord blood derived T regulatory cells Grant 9,273,282 - Godfrey , et al. March 1, 2	2016-03-01
Methods for the isolation and expansion of cord blood derived T regulatory cells Grant 9,187,727 - Godfrey , et al. November 17, 2	2015-11-17
Regulatory T cells and their use in immunotherapy and suppression of autoimmune responses Grant 9,181,526 - Blazar , et al. November 10, 2	2015-11-10
Methods for the Isolation and Expansion of Cord Blood Derived T Regulatory Cells App 20120282694 - Godfrey; Wayne R. ; et al.	2012-11-08
Regulatory T Cells and Their Use in Immunotherapy and Suppression of Autoimmune Responses App 20120207727 - Blazar; Bruce ; et al.	2012-08-16
Regulatory T cells and their use in immunotherapy and suppression of autoimmune responses Grant 8,129,185 - Blazar , et al. March 6, 2	2012-03-06
Rapamycin-resistant T cells and therapeutic uses thereof Grant 8,075,921 - Fowler , et al. December 13, 2	2011-12-13
Rapamycin-resistant T Cells And Therapeutic Uses Thereof App 20110052547 - Fowler; Daniel H. ; et al.	2011-03-03
Regulatory T Cells and Their Use in Immunotherapy and Suppression of Autoimmune Responses App 20100291678 - Blazar; Bruce ; et al.	2010-11-18
Activation and Expansion of T-Cells Using An Engineered Multivalent Signaling Platform as a Research Tool App 20100261269 - June; Carl ; et al.	2010-10-14
Activation and expansion of T-cells using an engineered multivalent signaling platform as a research tool Grant 7,745,140 - June , et al. June 29, 2	2010-06-29
Rapamycin-resistant T cells and therapeutic uses thereof Grant 7,718,196 - Fowler , et al. May 18, 2	2010-05-18
Activation and expansion of T-cells using an agent that provides a primary activation signal and another agent that provides a co-stimulatory signal Grant 7,670,781 - Riley , et al. March 2, 2	2010-03-02
Regulatory T cells and their use in immunotherapy and suppression of autoimmune responses Grant 7,651,855 - Blazar , et al. January 26, 2	2010-01-26
Activation and expansion of T-cells using an engineered multivalent signaling platform Grant 7,638,325 - June , et al. December 29, 2	2009-12-29
Activation and expansion of T-cells using an engineered multivalent signaling platform Grant 7,638,326 - June , et al. December 29, 2	2009-12-29
Rapamycin-resistant T cells and therapeutic uses thereof App 20060159667 - Fowler; Daniel H. ; et al.	2006-07-20
Methods for the isolation and expansion of cord blood derived T regulatory cells App 20060062763 - Godfrey; Wayne R. ; et al.	2006-03-23
Regulatory T cells and their use in immunotherapy and suppression of autoimmune responses App 20050196386 - Blazar, Bruce ; et al.	2005-09-08
Generation of use of tc1 and tc2 cells App 20040258661 - Fowler, Daniel ; et al.	2004-12-23
Methods of generating human cd4+ th1 cells App 20040241153 - Fowler, Daniel H. ; et al.	2004-12-02
Methods of generating human cd4+ th2 cells and uses thereof App 20040175827 - Fowler, Daniel H. ; et al.	2004-09-09
Activation and expansion of T-cells using an engineered multivalent signaling platform App 20040110290 - June, Carl ; et al.	2004-06-10
Activation and expansion of T-cells using an engineered multivalent signaling platform as a research tool App 20040101519 - June, Carl ; et al.	2004-05-27
Activation and expansion of T-cells using an engineered multivalent signaling platform App 20030224520 - June, Carl ; et al.	2003-12-04
System and methods for promoting expansion of polyclonal and antigen-specific cytotoxic T lymphocytes in response to artificial antigen presenting cells App 20030147869 - Riley, James ; et al.	2003-08-07

Company Registrations

NCAGE Code	3VND3	JUNE, CARL
CAGE Code	3VND3	JUNE, CARL
S.A.M. Registration	3VND3 [147299064]	JUNE, CARL

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.